Showing posts with label valuation. Show all posts
Showing posts with label valuation. Show all posts
Wednesday, December 22, 2010
HCA substitute S-1 for estimated $4.6BN IPO
In what may be a final cleanup prior to HCA's estimated $4.6bn IPO going effective, HCA filed a fresh S-1 and withdrew its May 2010 filing, saying the move was made in part because of the company's recent reoganization. HCA is a bellwether in many ways, and its offering and the market response, thereto, may yield benchmarks for the sector, with valuation subsequently affecting young ventures looking for capital. Here's The Deal's take on the filing (23 Dec).
Labels:
HCA,
healthcare,
IPO,
private equity,
public equities,
valuation
Saturday, September 19, 2009
Crow now Mercer Cap prez
At Memphis-based Mercer Capital, a business-valuation and investment banking firm, the retirement of Ken Patton led CEO Chris Mercer to elevate Matthew Crow to the president's post. The firm's release. Crow has been with Mercer Capital 15 years. He earned his master's at UNC Chapel Hill and his bachelor's at Vanderbilt University.
Subscribe to:
Posts (Atom)